Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
γδT cells represent a small percentage of T cells in circulation but are found in large numbers in certain organs. They are considered to be innate immune cells that can exert cytotoxic functions on target cells without MHC restriction. Moreover, γδT cells contribute to adaptive immune response via...
Main Authors: | Yuan Song, Yonghao Liu, Huey Yee Teo, Haiyan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.914839/full |
Similar Items
-
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
by: Megan Yuan, et al.
Published: (2024-03-01) -
Cancer immunotherapy using γδT cells: dealing with diversity
by: Wouter eScheper, et al.
Published: (2014-11-01) -
γδ T cells in immunotherapies for B-cell malignancies
by: Léa Rimailho, et al.
Published: (2023-06-01) -
Biological characteristics of γδT cells and application in tumor immunotherapy
by: Renhong Zhu, et al.
Published: (2023-01-01) -
The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
by: Yuxia Liu, et al.
Published: (2020-05-01)